HyOrc Secures €6.7M EU Grant and $7.5M Equity Line, Targets November Methanol Production
HYOR has more than doubled off its 52-week low of $0.009.
Summary
HyOrc landed a €6.7 million non-repayable STEP grant and a $7.5 million equity facility, addressing the going-concern risk flagged in its August 6 10-Q. The grant funds larger-scale expansion in Portugal, while the equity line supports a planned Nasdaq uplisting. Manufacturing of the first commercial unit is nearly done, with shipment set for September and initial methanol production targeted for November. The 50/50 joint venture with MO.RE.DA. formalizes the partnership and locks in the 3-TPD/1-TPD configuration. These milestones shift the company from survival mode to near-term revenue generation, though execution risk remains high given its thin cash position.
At the time of this announcement, HYOR was trading at $0.05 on OTC in the Energy & Transportation sector, with a market capitalization of approximately $37.9M. The 52-week trading range was $0.01 to $0.23. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.